Artwork

Content provided by Science Changing Life and Scripps Research. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Science Changing Life and Scripps Research or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Hugh Rosen: A physician-scientist’s guide to developing medicines

30:30
 
Share
 

Manage episode 418300544 series 1908208
Content provided by Science Changing Life and Scripps Research. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Science Changing Life and Scripps Research or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
More than 90% of drugs fail to make it from the lab bench to approval. How, then, has a physician-scientist like Hugh Rosen found so much success in developing medicines? Rosen, who’s the chair of molecular and cellular biology at Scripps Research, co-invented the drugs ozanimod (approved for multiple sclerosis and ulcerative colitis) and navacaprant (in Phase 3 trials for major depressive disorder). In this episode of Science Changing Life, listen in as Rosen unveils the success stories behind these groundbreaking treatments—shedding light on the challenges and triumphs shaping modern medicine. Rosen Lab: https://www.scripps.edu/rosen/index.html Scripps Research Magazine: magazine.scripps.edu/
  continue reading

46 episodes

Artwork
iconShare
 
Manage episode 418300544 series 1908208
Content provided by Science Changing Life and Scripps Research. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Science Changing Life and Scripps Research or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
More than 90% of drugs fail to make it from the lab bench to approval. How, then, has a physician-scientist like Hugh Rosen found so much success in developing medicines? Rosen, who’s the chair of molecular and cellular biology at Scripps Research, co-invented the drugs ozanimod (approved for multiple sclerosis and ulcerative colitis) and navacaprant (in Phase 3 trials for major depressive disorder). In this episode of Science Changing Life, listen in as Rosen unveils the success stories behind these groundbreaking treatments—shedding light on the challenges and triumphs shaping modern medicine. Rosen Lab: https://www.scripps.edu/rosen/index.html Scripps Research Magazine: magazine.scripps.edu/
  continue reading

46 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide